期刊文献+

TGFβ_1与Smad_(2/3)在乳腺癌组织中的表达及意义 被引量:1

Expression and significance of TGFβ_1 and Smad_(2/3) in breast cancer tissues
下载PDF
导出
摘要 目的研究TGFβ1与Smad2/3在乳腺癌组织中的表达,揭示其在乳腺癌中的信号转导通路。方法应用免疫组化SABC法检测62例乳腺癌组织中TGFβ1与Smad2/3的表达情况,利用SPSS19.0统计学软件分析TGFβ1与Smad2/3的差异性及相关性。结果 TGFβ1与Smad2/3在乳腺癌组织中呈高表达,阳性表达率依次为69.35%(43/62)和40.32%(25/62)。TGFβ1与Smad2/3在乳腺癌组织中的表达与年龄无关,TGFβ1与Smad2/3在组织学分级、病理学分类、TNM分期方面差异均有统计学意义(P<0.05)。TGFβ1与Smad2/3在乳腺癌组织中的表达呈正相关(r=0.261,P<0.05)。结论乳腺癌的发生可能与TGFβ1及Smad2/3信号转导途径发生异常,致使下游信号Smad2/3突变,增加瘤细胞与细胞外基质的相互作用、抑制免疫系统、增加血管形成等机制促进乳腺癌的浸润和转移有关。 Objective To study the expression of TGFβ1 and Smad2/3 in breast cancer tissues, and to demonstrate its signal transduction pathway in breast cancer. Methods Immunohistochemical SABC method was applied to test the ex- pression of TGFβ1 and Smad2/3 in 62 cases of breast cancer tissues. The statistically software of SPSS19.0 was applied to analyze the difference and correlation between TGFβ1 and Smad2/3. Results TGFβ1 and Smad2/3 were highly expressed in breast cancer tissues, and the positive expression rate was 69.35% (43/62) and 40.32% (25/62) respectively. The ex- pression of TGFβ1 and Smad2/3in breast cancer tissues was not correlated with the age, and the differences of TGFβ1and Smad2/3 in histological grade, pathological classification and TNM stage were all statistically significant (P〈0.05) The expression of TGFβ1 and the expression of Smad2/3 in breast cancer tissues were positively correlated (r=0.261, P〈0.05) Conclusion The possible reason of the occurrence of breast cancer is that the abnormal signal transduction pathway of TGFβ1 and Smad2/3, induces the mutation of downstream signal Smad2/3, and mechanisms such as strengthening interac- tions between tumor cells and extracellular matrix, inhibition of immunological system and improving angiopoiesis are used to promote the infiltration and metastasis of breast cancer
作者 牛蕾 雷丽
出处 《中国现代医生》 2015年第17期11-13,16,F0003,共5页 China Modern Doctor
关键词 乳腺癌 TGFΒ1 SMAD2/3 相关性 Breast cancer TGFβ1 Smad2/3 Corralation
  • 相关文献

参考文献15

  • 1Santibanez JF,P~rez-G6mez E,Fernandez LA,et al. The TGF-beta co-receptor endoglin modulates the expression and transforming potential of H-Ras[J]. Carcino genesis, 2010,31 (12) : 2145-2154.
  • 2Lampropoulos P,Zizi-Sermpetzoglou A,Rizos S,et al. TGF- beta signaling in colon eareino-genesis[J]. Cancer Letters, 2012,314(1) : 1-7.
  • 3Su E,Han X,Jiang G. The transforming growth factor be- tal/SMAD signaling pathway involved in human chronic myeloid leukemia[J]. Tumor,2010,96(5) :659-666.
  • 4Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer:Experience from a large study with long term fol- low up[J]. Histopathology, 1991,19(5) :403-410.
  • 5Azzopardi JG,Chepick OF,Hartmann WH, et al. Histo- logical classification of breast tumours[A]. In:WHO. His- tological Typing of Breast Tumours. 2nd,ed. Geneva: World Health Organization, 1981 : 15-16.
  • 6Wolff AC, Hammond ME,Schwartz JN, et al. American Society of Clinical Oneology/College of American Patholo- gists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J]. J Clin Oncol, 2007,25 ( 1 ) : 118-145.
  • 7Feng CW, Wang LD, Jiao LH,et al. Expression of p53, inducible nitric oxide synthase and vascular en- dothelial growth factor in gastric precancerous and cancer- ous lesions:Correlation with clinical features [J]. BMC Cancer. 2002.2(6) : 8-10.
  • 8吴巍,姚欣欣,朱辛奕.TGF-β在骨组织中作用的研究进展[J].吉林医药学院学报,2009,30(1):45-47. 被引量:12
  • 9玄延花,林贞花,李柱虎,玄东春,崔演.胃腺癌组织中TGFβ1及其受体的表达及意义[J].临床与实验病理学杂志,2007,23(6):724-726. 被引量:7
  • 10Yang L. TGFβ,apotent regulator of tumor microenviron- ment and host immune response,implication for therapy[J]. Curr Mol Med,2010,10(4) :374-380.

二级参考文献16

  • 1蒋滔,程祥荣,夏海斌,王贻宁.rhBMP-2/rhTGF-β_(1)联合应用对兔成骨样细胞增殖及分化的影响[J].口腔颌面修复学杂志,2005,6(1):1-3. 被引量:5
  • 2Chang J, Park K, Bang Y J, et al. Expression of transforming growth factor β type Ⅱ receptor reduces tumorgenisity in human gastric cancer cells[ J]. Cancer Res, 1997, 57 : 2856 - 2859.
  • 3Kim I Y, Ahn H J, Lang S, et al. Loss of expression of transforming growth factor β receptors is associated with poor prognosis in prostate cancer patients[J]. Clin Cancer Res, 1998,4:1625 - 1630.
  • 4Takanami I, Tanaka F, Hashizume T, et al. Boles of the transforming growth factor β1 and its type Ⅰ and Ⅱ receptors in the development of a pulmonary adenocarcinoma: results of an immunohistochemical study[ J ]. J Surg Oncol, 1997, 64:262 - 267.
  • 5Pasche B. Role of TGFβ1 in cancer[J]. J Cell Physiol,2001, 186 : 153 - 168.
  • 6Tsushima H, ho N, Tamura S, et al. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer[J]. Clin Cancer Res, 2001, 7 (5) : 1258 - 1262.
  • 7Yoshihiko M, Yoshihiyo K, Akira K. Role of transforming growth factor β1 invasion and metastasis in gastric carcinoma[ J]. J Clin Oncol, 1999, 17(4):607-614.
  • 8Lnoue T, Chung Y, Yashiro M. Transforming growth factorβ1 and hepatocyte growth factor, prouduced by gastric fibmblasts stimulate the invasiveness of seirrhous gastric cancer cells[ J]. Jpn J Cancer Res, 1997, 88(2) : 152 - 159.
  • 9B. Wildemann,G. Schmidmaier,N. Brenner,M. Hüning,R. Stange,N. P. Haas,M. Raschke. Quantification, Localization, and Expression of IGF-I and TGF-β1 During Growth Factor-Stimulated Fracture Healing[J] 2004,Calcified Tissue International(4):388~397
  • 10张胜利,王全平.骨质疏松骨折愈合过程中TGF-β_1mRNA的基因表达[J].第四军医大学学报,2001,22(6):497-500. 被引量:13

共引文献17

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部